Features

Features Read the complete September 2015 Digital Edition

Read the complete September 2015 Digital Edition

Click the link below to access the Digital Edition of the September 2015 MM&M, with all text, charts and pictures.

Features Washington Insider: A New Report

Washington Insider: A New Report

Features Back Talk: Hail to the . . . CEO?

Back Talk: Hail to the . . . CEO?

Features Viewpoint: Restrictions essential to spur creativity

Viewpoint: Restrictions essential to spur creativity

Features Viewpoint: Reframe your approach to video

Viewpoint: Reframe your approach to video

Features Private View: Bonnie Overton

Private View: Bonnie Overton

Features

Partner Forum: Will predictive analytics sell?

Can predictive analytics, embedded into CRM, fulfill the promise on which closed-loop marketing fell short: Allow pharma to harness data from rep visits to make their upcoming digital sales pitches smarter?

Features Social Engagement: Leveling the Field

Social Engagement: Leveling the Field

Social media has the potential to elevate challenger brands to the highest step on the podium. But with many companies still languishing in the blocks, medal-worthy performances remain few and far between. It's time for pharma to step up its social game, as James Chase reports

Features Brand Development Strategies: Golden Oldies

Brand Development Strategies: Golden Oldies

The rise of digital promotion and the need to wring every last drop of ROI from successful products have created a new niche: one with shoestring budgets, little to no sales-force support and competitors ready to pounce. Frank Celia explores late-lifecycle marketing and the companies and brands that manage to flourish there

Features Mobile Marketing: Dial M for Launch

Mobile Marketing: Dial M for Launch

Mobile is the multilayered ecosystem into which all products are now launched, so doing it right is crucial to commercial and outcomes success. James Chase draws on the insights of mobile health experts to compile six key considerations


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.